Neurofibroma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Sara Mohsin (talk | contribs) |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neurofibroma}} | {{Neurofibroma}} | ||
{{CMG}}; {{AE}} {{SC}} | {{CMG}}; {{AE}}{{S.M.}} {{SC}} | ||
==Overview== | ==Overview== | ||
There are no other diagnostic study findings associated with neurofibroma. | There are no other [[Diagnostic study of choice|diagnostic study]] findings associated with [[neurofibroma]]. | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
There are no other diagnostic study findings associated with neurofibroma. | There are no other [[Diagnostic study of choice|diagnostic study]] findings associated with [[neurofibroma]]. | ||
==References== | ==References== |
Latest revision as of 22:54, 28 April 2019
Neurofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neurofibroma other diagnostic studies On the Web |
American Roentgen Ray Society Images of Neurofibroma other diagnostic studies |
Risk calculators and risk factors for Neurofibroma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Shanshan Cen, M.D. [3]
Overview
There are no other diagnostic study findings associated with neurofibroma.
Other Diagnostic Studies
There are no other diagnostic study findings associated with neurofibroma.